モノクローナル抗体による癌治療 Development of cancer therapy using antibodies.:Development of cancer therapy using antibodies

この論文にアクセスする

この論文をさがす

著者

    • 山口 俊晴 YAMAGUCHI Toshiharu
    • 財団法人癌研究会付属病院消化器外科 Department of Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research

抄録

The historical aspects of the development of cancer therapy using antibodies were considered. And cancer treatment trials using antibody conducted in USA were introduced. At present the key antibody in the treatment of cancers is herceptin that bound to HER-2/neu. Many kinds of chemotherapeutic regimen had been combined with antibody therapy. Also some unique antibodies other than herceptin had been developed and clinical studies were conducted. The number of clinical study using antibody in Japan is still very small.

収録刊行物

  • Drug delivery system

    Drug delivery system 17(1), 29-34, 2002-01-10

    日本DDS学会

参考文献:  12件中 1-12件 を表示

被引用文献:  1件中 1-1件 を表示

各種コード

  • NII論文ID(NAID)
    10008131998
  • NII書誌ID(NCID)
    AN10084591
  • 本文言語コード
    JPN
  • 資料種別
    REV
  • ISSN
    09135006
  • データ提供元
    CJP書誌  CJP引用  J-STAGE 
ページトップへ